High Vista Strategies LLC Stoke Therapeutics, Inc. Transaction History

High Vista Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $861,927 - $1.46 Million	-47,594 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.65 - $34.44 $1.13 Million - $1.64 Million	47,594 New	47,594 $1.21 Million
Q2 2021 Aug 16, 2021	SELL	$30.53 - $41.09 $418,016 - $562,604	-13,692 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$36.08 - $69.81 $143,454 - $277,564	-3,976 Reduced 22.5%	13,692 $532,000
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $19,701 - $36,290	586 Added 3.43%	17,668 $1.09 Million
Q3 2020 Nov 16, 2020	SELL	$22.23 - $37.48 $14,493 - $24,436	-652 Reduced 3.68%	17,082 $572,000
Q2 2020 Aug 14, 2020	BUY	$20.26 - $29.73 $359,290 - $527,231	17,734 New	17,734 $423,000

124

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $446M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.